Cargando…

Direct, remote and combined ischemic conditioning in liver surgery

Liver ischemia-reperfusion injury is a major cause of postoperative liver dysfunction, morbidity and mortality following liver resection and transplantation. Ischemic conditioning has been shown to ameliorate ischemia-reperfusion injury in small animal models. It can be applied directly or remotely...

Descripción completa

Detalles Bibliográficos
Autores principales: Stankiewicz, Rafał, Grąt, Michał
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173344/
https://www.ncbi.nlm.nih.gov/pubmed/34131468
http://dx.doi.org/10.4254/wjh.v13.i5.533
_version_ 1783702708140638208
author Stankiewicz, Rafał
Grąt, Michał
author_facet Stankiewicz, Rafał
Grąt, Michał
author_sort Stankiewicz, Rafał
collection PubMed
description Liver ischemia-reperfusion injury is a major cause of postoperative liver dysfunction, morbidity and mortality following liver resection and transplantation. Ischemic conditioning has been shown to ameliorate ischemia-reperfusion injury in small animal models. It can be applied directly or remotely when cycles of ischemia and reperfusion are applied to a distant site or organ. Considering timing of the procedure, different protocols are available. Ischemic preconditioning refers to that performed before the duration of ischemia of the target organ. Ischemic perconditioning is performed over the duration of ischemia of the target organ. Ischemic postconditioning applies brief episodes of ischemia at the onset of reperfusion following a prolonged ischemia. Animal studies pointed towards suppressing cytokine release, enhancing the production of hepatoprotective adenosine and reducing liver apoptotic response as the potential mechanisms responsible for the protective effect of direct tissue conditioning. Interactions between neural, humoral and systemic pathways all lead to the protective effect of remote ischemic preconditioning. Despite promising animal studies, none of the aforementioned protocols proved to be clinically effective in liver surgery with the exception of morbidity reduction in cirrhotic patients undergoing liver resection. Further human clinical trials with application of novel conditioning protocols and combination of methods are warranted before implementation of ischemic conditioning in day-to-day clinical practice.
format Online
Article
Text
id pubmed-8173344
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-81733442021-06-14 Direct, remote and combined ischemic conditioning in liver surgery Stankiewicz, Rafał Grąt, Michał World J Hepatol Minireviews Liver ischemia-reperfusion injury is a major cause of postoperative liver dysfunction, morbidity and mortality following liver resection and transplantation. Ischemic conditioning has been shown to ameliorate ischemia-reperfusion injury in small animal models. It can be applied directly or remotely when cycles of ischemia and reperfusion are applied to a distant site or organ. Considering timing of the procedure, different protocols are available. Ischemic preconditioning refers to that performed before the duration of ischemia of the target organ. Ischemic perconditioning is performed over the duration of ischemia of the target organ. Ischemic postconditioning applies brief episodes of ischemia at the onset of reperfusion following a prolonged ischemia. Animal studies pointed towards suppressing cytokine release, enhancing the production of hepatoprotective adenosine and reducing liver apoptotic response as the potential mechanisms responsible for the protective effect of direct tissue conditioning. Interactions between neural, humoral and systemic pathways all lead to the protective effect of remote ischemic preconditioning. Despite promising animal studies, none of the aforementioned protocols proved to be clinically effective in liver surgery with the exception of morbidity reduction in cirrhotic patients undergoing liver resection. Further human clinical trials with application of novel conditioning protocols and combination of methods are warranted before implementation of ischemic conditioning in day-to-day clinical practice. Baishideng Publishing Group Inc 2021-05-27 2021-05-27 /pmc/articles/PMC8173344/ /pubmed/34131468 http://dx.doi.org/10.4254/wjh.v13.i5.533 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Minireviews
Stankiewicz, Rafał
Grąt, Michał
Direct, remote and combined ischemic conditioning in liver surgery
title Direct, remote and combined ischemic conditioning in liver surgery
title_full Direct, remote and combined ischemic conditioning in liver surgery
title_fullStr Direct, remote and combined ischemic conditioning in liver surgery
title_full_unstemmed Direct, remote and combined ischemic conditioning in liver surgery
title_short Direct, remote and combined ischemic conditioning in liver surgery
title_sort direct, remote and combined ischemic conditioning in liver surgery
topic Minireviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173344/
https://www.ncbi.nlm.nih.gov/pubmed/34131468
http://dx.doi.org/10.4254/wjh.v13.i5.533
work_keys_str_mv AT stankiewiczrafał directremoteandcombinedischemicconditioninginliversurgery
AT gratmichał directremoteandcombinedischemicconditioninginliversurgery